Moderna Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Bivalent Booster Candidate https://la-newswire.com/wp-content/themes/anemos/images/empty/thumbnail.jpg 150 150 Todd Todd https://la-newswire.com/wp-content/uploads/2021/09/Todd-93x96.jpg March 16, 2022 March 14, 2022